About
Fiona H. Marshall PhD is President of Biomedical Research, the innovation engine of Novartis, and a member of the Executive Committee of Novartis. Prior to joining Novartis in 2022, she was the Senior Vice President and Global Head of Discovery Sciences, Preclinical Development and Translational Medicine at MSD (Merck & Co in the US). Prior to joining Merck in 2018, Fiona was a founder and the Chief Scientific Officer of Heptares Therapeutics, a successful UK biotech NVF portfolio company focused on structure-based drug design. In 2015, Heptares was acquired by Japanese biotech company Sosei, where she continued as Chief Scientific Officer. Earlier in her career, Fiona was the Director of Molecular Pharmacology at Millennium Pharmaceuticals and spent 10 years at GSK, holding senior positions in Molecular Pharmacology and Neuroscience. She holds a BSc in Biochemistry from University of Bath and a PhD in Neuroscience from University of Cambridge. Fiona is the recipient of the 2012 WISE Women of Outstanding Achievement for Innovation and Entrepreneurship Award, the 2015 RSC Malcolm Campbell Award for chemistry, and the Vane Medal from the British Pharmacological Society. She is a Fellow of the Royal Society and the Academy of Medical Sciences, and an Honorary Fellow of both the British Pharmacological Society and Royal Society of Chemistry.
